Pathstone Family Office’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.89M | Buy |
|
|||||
|
2023
Q2 | $2.69M | Buy |
|
|||||
|
2023
Q1 | $1.99M | Sell |
|
|||||
|
2022
Q4 | $3.72M | Buy |
|
|||||
|
2022
Q3 | $4.44M | Buy |
|
|||||
|
2022
Q2 | $1.64M | Sell |
|
|||||
|
2022
Q1 | $2.53M | Buy |
|
|||||
|
2021
Q4 | $1M | Buy |
|
|||||
|
2021
Q3 | $598K | Buy |
|
|||||
|
2021
Q2 | $421K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $49K | Buy |
|
|||||
|
2020
Q3 | $0 | Hold |
|
|||||
|
2020
Q2 | $0 | Hold |
|
|||||
|
2020
Q1 | $0 | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2K | Sell |
|
|||||
|
2018
Q4 | $116K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $118K | Sell |
|
|||||
|
2017
Q1 | $95K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $1K | Buy |
|